Skip Navigation

British Journal of Anaesthesia 2008 101(4):439-441; doi:10.1093/bja/aen247
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in BJA
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Biccard, B. M.
Right arrow Articles by Howell, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biccard, B. M.
Right arrow Articles by Howell, S. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Board of Management and Trustees of the British Journal of Anaesthesia 2008. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Calcium channel blockers, beta-blockers, and perioperative cardiovascular stability

The first 10% of the full text of this article appears below.

It is contentious whether calcium channel blockers as a group offer any cardioprotection in the perioperative period for patients undergoing non-cardiac surgery. Meta-analyses of the cardioprotective efficacy of calcium channel blockers have resulted in conflicting results, with one meta-analysis having a sample size too small to draw any conclusions,1 and the other showing significantly reduced myocardial ischaemia and a significantly reduced composite of death, myocardial infarction, or congestive heart failure.2 However, of all the studies identified, only a single study of 50 patients specifically examined dihydropyridines.3

Dihydropyridines have properties which are theoretically hazardous in the perioperative period for patients undergoing major non-cardiac surgery. Of particular concern in the perioperative period is that the vasodilation produced by dihydropyridines causes reflex adrenergic activation producing an . . . [Full Text of this Article]

B. M. Biccard1,* and S. J. Howell2

1 Department of Anaesthetics
Nelson R. Mandela School of Medicine
Private Bag 7
Congella
Kwazulu-Natal 4013
South Africa
2 University of Leeds
Leeds General Infirmary
Great George Street
Leeds LS1 3EX
UK

* E-mail: bruce.biccard@nda.ox.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in BJA:

In the October 2008 BJA...

BJA 2008 101: NP. [Extract] [Full Text]  



This article has been cited by other articles:


Home page
Br J AnaesthHome page
C. S. Reilly
Can we accurately assess an individual's perioperative risk?
Br. J. Anaesth., December 1, 2008; 101(6): 747 - 749.
[Full Text] [PDF]